过渡性腺素调节了在背面的拉菲核中间接释放的血清激素
Kailash Shrestha1, B Jill Venton1
1Department of Chemistry, University of Virginia, Charlottesville, Virginia 22901, United States.
ACS chemical neuroscience
|February 9, 2024
概括
过渡性腺素迅速抑制大脑中的血清释放,但不是通过腺素受体. 这种效应是由血清素1A自身受体介导的,这表明抑郁症和脑损伤的新治疗点.
科学领域:
- 神经科学是一个神经科学.
- 神经化学 神经化学
背景情况:
- 腺素通过A1受体快速调节多巴胺和谷氨酸.
- 氨酸对血清释放的作用仍然没有研究.
研究的目的:
- 为了研究腺素对小鼠背脊拉菲核 (DRN) 中的血清释放的快速调节作用.
- 为了确定参与腺素调节血清素释放的特定受体.
主要方法:
- 快速扫描循环电压测量用于测量小鼠大脑切片中的血清释放.
- 腺素被快速微注射,以模仿损伤期间的释放.
- 用基因淘汰赛小鼠 (A1KO,A2AKO) 和受体对抗剂来识别涉及的受体.
主要成果:
- 过渡性腺素的应用显著减少了DRN中电气引起的血清释放.
- 这种抑制作用是暂时的,随着腺清除,血清释放恢复到基线.
- 这种抑制并非由A1,A3或A2A腺受体介导.
- 一种选择性的5HT1A自身受体对抗剂取消了腺的抑制作用.
结论:
- 过渡性腺因通过5HT1A自身受体调节DRN的血清释放,而不是腺受体.
- 这一发现揭示了快速神经递质调节的新机制.
- 对理解和治疗抑郁症和脑损伤的含义是显著的.
相关概念视频
Drugs Affecting Neurotransmitter Release or Uptake
1.1K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.1K
Adrenergic Agonists: Indirect-Acting Agents
1.6K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.6K
Adrenergic Neurons: Neurotransmission
3.8K
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which...
Synthesis: Catecholamine synthesis requires tyrosine, which...
3.8K
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
255
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
255
Antidepressant Drugs: MAOIs and Other Agents
230
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
230
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K


